Clorox (NYSE:CLX) had its price target trimmed by Morgan Stanley from $140.00 to $133.00 in a research report sent to investors on Monday. The brokerage currently has an equal weight rating on the stock.

A number of other analysts have also issued reports on the stock. Deutsche Bank started coverage on shares of Clorox in a research note on Wednesday, December 13th. They set a hold rating and a $142.00 price target on the stock. Wells Fargo & Co reiterated a hold rating and set a $130.00 price target on shares of Clorox in a research note on Wednesday, December 13th. Royal Bank of Canada reiterated a hold rating and set a $115.00 price target on shares of Clorox in a research note on Sunday, October 8th. Consumer Edge upgraded shares of Clorox from a neutral rating to an outperform rating in a research note on Friday, November 10th. Finally, Bank of America upgraded shares of Clorox from an underperform rating to a neutral rating and set a $155.00 price target on the stock in a research note on Thursday, January 4th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $132.26.

Shares of Clorox (NYSE CLX) opened at $127.82 on Monday. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22. The stock has a market cap of $16,790.00, a PE ratio of 21.06, a price-to-earnings-growth ratio of 3.11 and a beta of 0.31. Clorox has a one year low of $124.09 and a one year high of $150.40.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The business’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 earnings per share. sell-side analysts anticipate that Clorox will post 6.08 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.63%. Clorox’s payout ratio is 55.35%.

In related news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the sale, the senior vice president now directly owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.00% of the stock is currently owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. Moors & Cabot Inc. increased its stake in shares of Clorox by 1.2% during the second quarter. Moors & Cabot Inc. now owns 2,557 shares of the company’s stock worth $339,000 after buying an additional 30 shares during the period. WFG Advisors LP increased its stake in shares of Clorox by 7.2% during the second quarter. WFG Advisors LP now owns 1,571 shares of the company’s stock worth $209,000 after buying an additional 106 shares during the period. Candriam Luxembourg S.C.A. increased its stake in shares of Clorox by 3.8% during the fourth quarter. Candriam Luxembourg S.C.A. now owns 10,997 shares of the company’s stock worth $1,636,000 after buying an additional 398 shares during the period. Cetera Investment Advisers increased its stake in shares of Clorox by 17.9% during the second quarter. Cetera Investment Advisers now owns 2,627 shares of the company’s stock worth $348,000 after buying an additional 399 shares during the period. Finally, Stock Yards Bank & Trust Co. increased its stake in shares of Clorox by 8.4% during the third quarter. Stock Yards Bank & Trust Co. now owns 5,172 shares of the company’s stock worth $683,000 after buying an additional 400 shares during the period. Hedge funds and other institutional investors own 73.68% of the company’s stock.

WARNING: “Clorox (CLX) Price Target Cut to $133.00 by Analysts at Morgan Stanley” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/02/08/clorox-clx-price-target-cut-to-133-00-by-analysts-at-morgan-stanley.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.